drugset / Trial / NCT03910634

IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients

NCT03910634 ↗

Phase 2 Unknown 264 enrolled Sun Yat-sen University
RandomizedParallel-groupSingle-blindTreatment

Summary

An open, single-center, randomized controlled phase II clinical trial to compare the efficacy and safety of conformal intensity modulated radiation therapy (IMRT) combined with carboplatin and IMRT combined with carboplatin and 5-FU in elderly patients with locally advanced esophageal squamous cell carcinoma at high risk of chemotherapy

Timeline

Start
2019-04-09
Primary completion
2020-12-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator fluorouracil Small molecule 1.33 g Intravenous
Background Carboplatin Small molecule 2 unknown Intravenous

Indications